Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (dysadherin) gene

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 11, 2012, Pages

  Colamaio, Marianna ^a,b   Calì, Gaetano ^a   Sarnataro, Daniela ^b   Borbone, Eleonora ^a,b   Pallante, Pierlorenzo ^a,b   Decaussin Petrucci, Myriam ^c   Nitsch, Lucio ^a,b   Croce, Carlo Maria ^d   Battista, Sabrina ^a,b   Fusco, Alfredo ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^c UNIVERSITÉ LYON 1   (France)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSADHERIN; MEMBRANE PROTEIN; MICRORNA; PROTEIN LET 7A; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FXYD5 GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYROID FOLLICULAR CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ANIMALS; CELL ADHESION; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; DOWN-REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; MICRORNAS; NEOPLASM PROTEINS; RATS; THYROID GLAND; THYROID NEOPLASMS;

RATTUS;

EID: 84868628472     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1929     Document Type: Article

References (39)

1. Kondo T, Ezzat S, Asa SL 2006 Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292-306
2. Sobrinho-Simões M, Eloy C, Magalhães J, Lobo C, Amaro T 2011 Follicular thyroid carcinoma. Mod Pathol 24(Suppl 2):S10-S18
3. Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimeno C, Barreiro-Morandeira F, Lado-Abeal J, Araujo Vilar D, Argueso R, Barca O, Botana M, Cabezas-Agrícola JM, Catalina P, Dominguez Gerpe L, Fernandez T, Mato A, Nuño A, Penin M, Victoria B 2008 Prevalence of mutations inTSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Eur J Endocrinol 159:623-631
4. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA 2000 PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma. Science 289:1357-1360 (Pubitemid 30656054)
5. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464
6. Garzon R, Calin GA, Croce CM 2009 MicroRNAs in cancer. Annu Rev Med 60:167-179
7. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M, Croce CM, Fusco A 2006 MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13:497-508 (Pubitemid 43886672)
8. Visone R, Pallante P, Vecchione A, Cirombella R, Ferracin M, Ferraro A, Volinia S, Coluzzi S, Leone V, Borbone E, Liu CG, Petrocca F, Troncone G, Calin GA, Scarpa A, Colato C, Tallini G, Santoro M, Croce CM, Fusco A 2007 Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26:7590-7595 (Pubitemid 350207711)
9. Ruby JG, Jan C, Player C, Axtell MJ, Lee W, Nusbaum C, Ge H, Bartel DP 2006 Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in C. elegans. Cell 127:1193-1207 (Pubitemid 44894525)
10. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC 2006 Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9:189-198 (Pubitemid 43357945)
11. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E 2007 Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131:1109-1123 (Pubitemid 350235025)
12. Zhang HH, Wang XJ, Li GX, Yang E, Yang NM 2007 Detection of let-7a microRNA by real-time PCR in gastric carcinoma. World J Gastroenterol 13:2883-2888 (Pubitemid 47007908)
13. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T 2008 Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 105:3903-3908 (Pubitemid 351723497)
14. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ 2005 RAS is regulated by the let-7 microRNA family. Cell 120:635-647 (Pubitemid 40343076)
15. Lee YS, Dutta A 2007 The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21:1025-1030 (Pubitemid 46686471)
16. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT 2008 Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40:43-50
17. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L, Brown D, Slack FJ 2007 The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67:7713-7722 (Pubitemid 47281364)
18. Colamaio M, Borbone E, Russo L, Bianco M, Federico A, Califano D, Chiappetta G, Pallante P, Troncone G, Battista S, Fusco A 2011 MiR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting. J Clin Endocrinol Metab 96:E1915-E1924
19. Estour B, Van Herle AJ, Juillard GJ, Totanes TL, Sparkes RS, Giuliano AE, Klandorf H 1989 Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch B Cell Pathol Incl Mol Pathol 57:167-174 (Pubitemid 19170572)
20. Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M, Vecchio G 1987 One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol Cell Biol 7:3365-3370
21. Pallante P, Berlingieri MT, Troncone G, Kruhoffer M, Orntoft TF, Viglietto G, Caleo A, Migliaccio I, Decaussin-Petrucci M, Santoro M, Palombini L, Fusco A 2005 UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas. Br J Cancer 93:464-471
22. Di Agostino S, Fedele M, Chieffi P, Fusco A, Rossi P, Geremia R, Sette C 2004 Phosphorylation of high-mobility group protein A2 by Nek2 kinase during the first meiotic division in mouse spermatocytes. Mol Biol Cell 15:1224-1232 (Pubitemid 38316229)
23. Shimamura T, Yasuda J, Ino Y, Gotoh M, Tsuchiya A, Nakajima A, Sakamoto M, Kanai Y, Hirohashi S 2004 Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. Cancer Res 64:6989-6995 (Pubitemid 39331008)
24. Naik MU, Naik UP 2006 Junctional adhesion molecule-A-induced endothelial cell migration on vitronectin is integrin α v β 3 specific. J Cell Sci 119:490-499
25. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM 2004 An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 101:9740-9744 (Pubitemid 38869306)
26. Sato H, Ino Y, Miura A, Abe Y, Sakai H, Ito K, Hirohashi S 2003 Dysadherin: expression and clinical significance in thyroid carcinoma. J Clin Endocrinol Metab 88:4407-4412 (Pubitemid 37153750)
27. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T 2007 Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39:673-677 (Pubitemid 46676103)
28. Ricarte-Filho JC, Fuziwara CS, Yamashita AS, Rezende E, da-Silva MJ, Kimura ET 2009 Effects of let-7 microRNA on cell growth and differentiation of papillary thyroid cancer. Transl Oncol 2:236-241
29. Müller DW, Bosserhoff AK 2008 Integrin β 3 expression is regulated by let-7a miRNA in malignant melanoma. Oncogene 27:6698-6706
30. Liang S, He L, Zhao X, Miao Y, Gu Y, Guo C, Xue Z, Dou W, Hu F, Wu K, Nie Y, Fan D 2011 MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One 6:e18409
31. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, Feig C, Lengyel E, Peter ME 2007 Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 104:11400-11405 (Pubitemid 47175152)
32. Sweadner KJ, Rael E 2000 The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression. Genomics 68:41-56
33. Fu X, Kamps MP 1997 E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol Cell Biol 17:1503-1512 (Pubitemid 27097380)
34. Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S 2002 Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci USA 99:365-370 (Pubitemid 34060368)
35. Nam JS, Hirohashi S, Wakefield LM 2007 Dysadherin: a new player in cancer progression. Cancer Lett 255:161-169 (Pubitemid 47268636)
36. Lubarski I, Karlish SJ, Garty H 2007 Structural and functional interactions between FXYD5 and the Na+-K+-ATPase. Am J Physiol Renal Physiol 293:F1818-F1826 (Pubitemid 350179607)
37. Guo H, Ingolia NT, Weissman JS, Bartel DP 2010 Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466:835-840
38. Park JR, Kim RJ, Lee YK, Kim SR, Roh KJ, Oh SH, Kong G, Kang KS, Nam JS 2011 Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells. J Hepatol 54:122-131
39. Dröge P, Davey CA 2008 Do cells let-7 determine stemness? Cell Stem Cell 2:8-9